Khalil Choucair

13PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersMolecular targetsNeurology and neuromuscular diseasesCancer geneticsFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 24, 2026
Longitudinal Treatment Outcomes in Patients With Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer: Results From a Multinational Registry-Based Study in a Predominantly Western Population.

|Nov 27, 2025
Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges.

Khalil Choucair, Hafsa Imtiaz, Md Hafiz Uddin

|Nov 27, 2025
An Update on Novel Pharmacotherapies for the Treatment of Neuroendocrine Tumors.

Khalil Choucair, Roupen Odabashian, Sushmita Nanja Reddy

|May 07, 2025
Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations.

Ibrahim Azar, Husain Yar Khan, Sahar F Bannoura

|Jan 31, 2025
Molecular and immune landscape of tumours in geriatric patients with non-small cell lung cancer, melanoma and renal cell carcinoma.

Khalil Choucair, Andrew Elliott, Matthew James Oberley

|Feb 08, 2024
Influence of <i>TP53</i> Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in <i>STK11</i>-Mutant Non-Small-Cell Lung Cancer.

Abdul Rafeh Naqash, Charalampos S Floudas, Etan Aber

Pageof 3

Frequent Collaborators

2 joint publications

Asfar Sohail Azmi

2 joint publications

Misako Nagasaka

2 joint publications

Hirva Mamdani

1 joint publications

Morhaf Al Achkar